Upcoming Events

Quality is critically important to the success of Life Sciences companies. The Foundations in Quality for the Life Sciences Industry provides presents concepts, tools and techniques for real world, on‐the‐job application of quality that is practical for a wide range of organizations. It is targeted for the application of quality in life sciences, including, but not limited to: biotechnology, pharmaceuticals, biomedical technologies, life systems technologies, nutraceuticals, cosmeceuticals, food processing, environmental, biomedical devices, and organizations and institutions that devote the majority…

The Orphan Drug Act (ODA) defines a rare disease as a disease or condition that affects less than 200,000 people in the United States.  Within this range we see conditions like sickle cell disease with a prevalence of over 100,000, down to rare genetic diseases that may occur in a handful of patients. As approaches to clinical development are constrained by issues of enrollment and statistical powering, the categories defined by prevalence distribution (rare, ultra-rare and uber-rare) require differing approaches…

Engineering the Next Wave of Immunotherapy Friday, September 17, 2021 8:30 a.m. EDT on Zoom The 19th Annual Koch Institute Summer Symposium will be held virtually on September 17, 2021 and will focus on cancer immunotherapy. Register now (https://mit.zoom.us/webinar/register/WN_iD8S9uJRQZuzXxZG4Ef9uA). Cancer immunotherapy has revolutionized the landscape of cancer treatment, our thinking of tumor biology and clinical practice. Following the groundbreaking successes of checkpoint blockade therapy and CAR T cell therapy, culminating in multiple FDA-approved treatments and the awarding of the 2018…

Join us to celebrate the launch of the first Life Sciences Apprenticeship Program in Massachusetts, providing candidates an alternative pathway to careers in biomanufacturing and clinical trials. This community event will introduce the first two cohorts of apprentices and highlight participating employers. We will also hear from key public officials committed to workforce development initiatives, locally to nation wide. Honorary Remarks By: United States Secretary of Labor Marty Walsh Massachusetts Secretary of Labor and Workforce Development Rosalin Acosta Representative Lori Trahan,…

Applications of artificial intelligence in health care are expanding rapidly. Despite its great long-term potential, risks and challenges remain for both AI developers and their partners in health care, the life sciences industry and digital health. This Harvard Medical School Executive Education program will allow leaders across the ecosystem to gain insights into what it takes to successfully utilize AI in the unique cultural, economic and regulatory context of health care. Interactive sessions will address technical concepts as well as…

Digital transformation in health care is happening at an increasingly rapid pace. The current global health care crisis is only bolstering the need for technology to provide meaningful solutions. Digital health technologies can make it more convenient for a patient to make an appointment. They can make it easier for doctors to access the right information at the right time. They can make it more efficient for a health system to manage their population and deliver high-value, high-quality care at…